Latest Insider Transactions at Medpace Holdings, Inc. (MEDP)
This section provides a real-time view of insider transactions for Medpace Holdings, Inc. (MEDP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medpace Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medpace Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2024
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+29.12%
|
$480,000
$32.05 P/Share
|
|
Nov 19
2024
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+10.34%
|
$240,000
$32.05 P/Share
|
|
Sep 30
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62
+1.17%
|
-
|
|
Sep 30
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
71
+10.73%
|
-
|
|
Sep 30
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
78
+0.36%
|
-
|
|
Aug 23
2024
|
Robert O. Kraft Director |
SELL
Open market or private sale
|
Direct |
3,774
-87.89%
|
$1,471,860
$390.73 P/Share
|
|
Aug 23
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,774
+46.78%
|
$158,508
$42.62 P/Share
|
|
Aug 22
2024
|
Robert O. Kraft Director |
SELL
Open market or private sale
|
Direct |
4,353
-89.33%
|
$1,697,670
$390.73 P/Share
|
|
Aug 22
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,353
+47.18%
|
$182,826
$42.62 P/Share
|
|
Aug 05
2024
|
Susan E Burwig Exec. VP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+46.51%
|
$4,500,000
$90.65 P/Share
|
|
Jun 30
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
62
+1.19%
|
-
|
|
Jun 30
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72
+12.16%
|
-
|
|
Jun 30
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
78
+0.36%
|
-
|
|
Jun 05
2024
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
7,681
-50.6%
|
$3,080,081
$401.2 P/Share
|
|
May 28
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
5,695
-0.86%
|
$2,249,525
$395.49 P/Share
|
|
May 24
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
3,987
-0.6%
|
$1,574,865
$395.22 P/Share
|
|
May 22
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
55
-0.01%
|
$22,000
$400.0 P/Share
|
|
May 20
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
4,020
-0.6%
|
$1,608,000
$400.19 P/Share
|
|
May 16
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
7,060
-1.05%
|
$2,845,180
$403.09 P/Share
|
|
May 15
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
32,282
-4.56%
|
$13,074,210
$405.13 P/Share
|
|
May 10
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
4,956
-0.7%
|
$1,992,312
$402.89 P/Share
|
|
May 09
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
3,486
-0.49%
|
$1,394,400
$400.17 P/Share
|
|
May 08
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
4,782
-0.66%
|
$1,912,800
$400.58 P/Share
|
|
May 07
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
28,032
-3.74%
|
$11,324,928
$404.48 P/Share
|
|
May 06
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
24,372
-3.15%
|
$9,773,172
$401.73 P/Share
|
|
May 02
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
3,396
-0.44%
|
$1,358,400
$400.44 P/Share
|
|
May 01
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
12,934
-1.64%
|
$5,186,534
$401.56 P/Share
|
|
Apr 30
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
1,828
-0.23%
|
$731,200
$400.31 P/Share
|
|
Apr 29
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Direct |
15,102
-1.87%
|
$6,040,800
$400.69 P/Share
|
|
Mar 31
2024
|
Robert O. Kraft Director |
BUY
Exercise of conversion of derivative security
|
Direct |
72
+13.85%
|
-
|
|
Mar 31
2024
|
Cornelius P. Mc Carthy Iii Director |
BUY
Exercise of conversion of derivative security
|
Direct |
63
+1.22%
|
-
|
|
Mar 31
2024
|
Brian T Carley Director |
BUY
Exercise of conversion of derivative security
|
Direct |
79
+0.36%
|
-
|
|
Mar 15
2024
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
102
-0.67%
|
$41,106
$403.0 P/Share
|
|
Mar 14
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
250
-50.0%
|
$102,250
$409.87 P/Share
|
|
Mar 14
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$42,000
$84.36 P/Share
|
|
Mar 08
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.53%
|
$10,200,000
$408.71 P/Share
|
|
Mar 08
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
25,000
-0.53%
|
$10,200,000
$408.71 P/Share
|
|
Mar 07
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
75,000
-1.55%
|
$30,750,000
$410.74 P/Share
|
|
Mar 07
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,000
-1.55%
|
$30,750,000
$410.74 P/Share
|
|
Mar 07
2024
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
472
-100.0%
|
$195,880
$415.0 P/Share
|
|
Mar 07
2024
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+50.0%
|
$25,488
$54.99 P/Share
|
|
Mar 06
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
100,000
-2.03%
|
$41,200,000
$412.98 P/Share
|
|
Mar 06
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.03%
|
$41,200,000
$412.98 P/Share
|
|
Mar 05
2024
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,679
+45.12%
|
$1,591,110
$90.65 P/Share
|
|
Mar 05
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-1.0%
|
$20,100,000
$402.7 P/Share
|
|
Mar 05
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-1.0%
|
$20,100,000
$402.7 P/Share
|
|
Mar 04
2024
|
Jesse J Geiger President |
SELL
Open market or private sale
|
Direct |
22,321
-85.37%
|
$8,995,363
$403.03 P/Share
|
|
Mar 04
2024
|
Jesse J Geiger President |
BUY
Exercise of conversion of derivative security
|
Direct |
22,321
+46.06%
|
$2,008,890
$90.65 P/Share
|
|
Mar 04
2024
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-0.99%
|
$20,150,000
$403.12 P/Share
|
|
Mar 04
2024
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.99%
|
$20,150,000
$403.12 P/Share
|